Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
26.03
-0.50 (-1.88%)
At close: Feb 12, 2026

SHE:003020 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
4,8973,4564,4953,9564,2483,185
Market Cap Growth
39.23%-23.11%13.63%-6.89%33.39%-
Enterprise Value
4,6273,2304,1803,3103,6312,938
Last Close Price
25.7517.5022.3319.5120.9515.55
PE Ratio
30.3021.5219.8318.9024.6723.57
Forward PE
-15.8317.14---
PS Ratio
3.322.282.371.531.871.68
PB Ratio
2.521.812.402.673.262.71
P/TBV Ratio
3.022.223.002.833.502.79
P/FCF Ratio
40.3480.29732.38--27.39
P/OCF Ratio
18.9217.5022.0719.7226.7718.47
EV/Sales Ratio
3.142.132.201.281.601.55
EV/EBITDA Ratio
19.3514.2417.3114.9918.1718.42
EV/EBIT Ratio
36.5621.2620.3116.9921.0720.46
EV/FCF Ratio
38.1175.04681.13--25.26
Debt / Equity Ratio
0.030.060.050.010.02-
Debt / EBITDA Ratio
0.280.500.350.060.12-
Debt / FCF Ratio
0.552.7614.41---
Net Debt / Equity Ratio
-0.21-0.20-0.25-0.42-0.48-0.65
Net Debt / EBITDA Ratio
-1.81-1.72-1.97-2.85-3.15-4.81
Net Debt / FCF Ratio
-3.43-9.05-77.5613.7422.30-6.59
Asset Turnover
0.570.600.831.361.421.56
Inventory Turnover
2.182.073.085.887.166.77
Quick Ratio
1.641.601.621.612.983.08
Current Ratio
2.212.042.122.333.723.77
Return on Equity (ROE)
8.27%8.05%13.95%15.03%13.90%15.32%
Return on Assets (ROA)
3.07%3.75%5.59%6.41%6.71%7.40%
Return on Invested Capital (ROIC)
7.28%9.23%16.64%22.29%27.55%30.97%
Return on Capital Employed (ROCE)
6.10%7.60%10.60%13.00%12.80%12.00%
Earnings Yield
3.32%4.65%5.04%5.29%4.05%4.24%
FCF Yield
2.48%1.25%0.14%-1.16%-0.66%3.65%
Dividend Yield
1.94%2.86%1.87%1.64%1.65%1.59%
Payout Ratio
67.87%50.40%27.03%30.99%26.90%20.78%
Buyback Yield / Dilution
0.64%0.47%-1.75%-0.49%-33.01%-0.03%
Total Shareholder Return
2.56%3.33%0.12%1.15%-31.37%1.56%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.